The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy

MLA

Backx, M., et al. The Cost of Treatment Failure: Resource Use and Costs Incurred by Hepatitis C Virus Genotype 1-Infected Patients Who Do or Do Not Achieve Sustained Virological Response to Therapy. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312899065&authtype=sso&custid=ns315887. Accessed 3 Dec. 2024.

APA

Backx, M., Lewszuk, A., White, J. R., Cole, J., Sreedharan, A., van Sanden, S., Diels, J., Lawson, A., Neal, K. R., Wiselka, M. J., Ito, T., & Irving, W. L. (n.d.). The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy.

Chicago

Backx, M., A. Lewszuk, J.R. White, J. Cole, A. Sreedharan, S. van Sanden, J. Diels, et al. 2024. “The Cost of Treatment Failure: Resource Use and Costs Incurred by Hepatitis C Virus Genotype 1-Infected Patients Who Do or Do Not Achieve Sustained Virological Response to Therapy.” Accessed December 3. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1312899065&authtype=sso&custid=ns315887.